🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Klaria Pharma Holding AB (KLAR)

Stockholm
Currency in SEK
0.344
-0.012(-2.81%)
Closed
KLAR Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
0.3300.359
52 wk Range
0.1401.145
Key Statistics
Edit
Prev. Close
0.356
Open
0.354
Day's Range
0.33-0.359
52 wk Range
0.14-1.145
Volume
390.13K
Average Volume (3m)
323.5K
1-Year Change
-30.08%
Book Value / Share
0.1
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KLAR Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Klaria Pharma Holding AB Company Profile

Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company. It develops Sumatriptan for the treatment of migraine. The company also develops Epinephrine/Adrenaline, which is in Phase I clinical trial for the treatment of acute allergic reaction. In addition, its pre-clinical product is Sirolimus for prevention of organ transplant rejection. Further, the company focuses on the commercialization of cannabis/cannabinoids. Klaria Pharma Holding AB (publ.) was incorporated in 2014 and is headquatered in Uppsala, Sweden.

Compare KLAR to Peers and Sector

Metrics to compare
KLAR
Peers
Sector
Relationship
P/E Ratio
−1.2x−5.1x−0.6x
PEG Ratio
−0.06−0.130.00
Price/Book
3.9x3.2x2.6x
Price / LTM Sales
−7.0x14.1x3.2x
Upside (Analyst Target)
107.7%36.9%49.4%
Fair Value Upside
Unlock3.2%7.8%Unlock

FAQ

What Is the Klaria Pharma Holding AB (KLAR) Stock Price Today?

The Klaria Pharma Holding AB stock price today is 0.344

What Stock Exchange Does Klaria Pharma Holding AB Trade On?

Klaria Pharma Holding AB is listed and trades on the Stockholm stock exchange.

What Is the Stock Symbol for Klaria Pharma Holding AB?

The stock symbol for Klaria Pharma Holding AB is "KLAR."

What Is the Klaria Pharma Holding AB Market Cap?

As of today, Klaria Pharma Holding AB market cap is 49.80M.

What is Klaria Pharma Holding AB Earnings Per Share?

The Klaria Pharma Holding AB EPS is -0.348.

What Is the Next Klaria Pharma Holding AB Earnings Date?

Klaria Pharma Holding AB will release its next earnings report on 28 Feb 2025.

From a Technical Analysis Perspective, Is KLAR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.